UMC downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Bruce Lu downgraded UMC (UMC) to Sell from Neutral with a price target of NT$40.50, down from NT$44.50 as part of a broader research note citing 'heightened' appreciation of Taiwan currency vs. US Dollar. The currency mismatch, where UMC's revenues are highly USD-denominated and the majority of its operating costs are based in TWD, will directly erode the company's profitability, the analyst tells investors in a research note. The firm further cites the headwinds of intensifying competition from mainland Chinese peers still remaining as the key downside risk to the company, along with the increasing depreciation, rising costs, and unfavorable FX trend.
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Stock market today: S&P 500, Dow, Nasdaq mixed as US and China reboot trade talks
US stocks were mixed on Monday as investors looked to renewed US-China trade talks for signs either side is willing to dial down tensions and reach a tariff deal. The S&P 500 (^GSPC) rose 0.1% after the benchmark edged above 6,000 to notch its highest close since February. The Dow Jones Industrial Average (^DJI) fell 0.4% while the tech-heavy Nasdaq Composite (^IXIC) drifted up 0.4%. The focus is on high-level US-China trade talks that began in London on Monday, after a phone call between President Trump and Chinese President Xi last week. Read more: The latest on Trump's tariffs The stakes are high amid warnings that tariff barriers will harm economies worldwide — the US in particular. Investors are looking for a revival of the momentum shown in the Geneva pact in mid-May. Relations have soured since then, with the US and China accusing each other of not keeping to the trade truce and ratcheting up pressures in other areas. For now, markets appear to have shaken off the volatility that has plagued markets following Trump's early-April tariff hikes. Stocks ended last week on a high note, as encouraging jobs data helped ease fears of a recession fueled by his policy overhaul. The economic highlight this week is May US consumer inflation print due on Friday, with the wholesale inflation report ushering it in on Thursday. On the corporate front, Apple (AAPL) kicks off its big annual WWDC developers conference on Monday. Wall Street is watching for more insight into the company's AI plans, though not on the lines of last year's splashy announcements. Meanwhile, investors are keeping a wary eye on escalating tensions in Los Angeles after Trump sent in the National Guard to deal with anti-deportation protests. Circle's stock (CRCL) surged for a third day in a row on Monday following its blockbuster IPO last week. Shares of the stablecoin issuer gained more than 15% to trade near $122 per share, raising the company's market cap to roughly $24 billion. The move follows gains on Thursday and Friday, when the stock rose as much as 200% shortly after its long-anticipated public market debut. Stocks edged higher on Monday amid hopes that US-China trade talks will ease tariff tensions and eventually lead to a permanent deal between the two leading economies. The S&P 500 (GSPC) rose to just above the flat line, after the broad benchmark closed on Friday at its highest level since February. The Dow Jones Industrial Average (^DJI) gained 0.1%, while the tech-heavy Nasdaq Composite (^IXIC) edged 0.2% higher. High-level trade talks between Beijing and Washington began in London on Monday. This follows a phone call between President Trump and Chinese leader Xi Jinping last week. Apple's annual Worldwide Developers Conference (WWDC) kicks off in Cupertino, Calif., today. While investors may get another taste of artificial intelligence features, including AI-powered Siri, Apple isn't expected to deliver any big announcements. The company will likely showcase new features and designs for iOS, iPadOS, macOS, and watchOS. There's always a chance it will debut a new piece of hardware too. Apple (AAPL) stock rose 0.5% in premarket trading ahead of the event. Read our tech editor's preview of everything to expect from Apple WWDC 2025. Robinhood (HOOD) stock slipped 4% after it didn't make it into the benchmark S&P 500 index as some speculated it might. S&P Dow Jones Indices did not make any changes to S&P 500 membership as part of its quarterly rebalancing. Reuters reports: Read more here. Shares of Warner Bros. Discovery (WBD) rose more than 6% in premarket trading on Monday after the media company said it would split into two companies. Warner Bros. will separate its studios and streaming business, which includes HBO Max, and its cable television networks, including CNN. The split is expected to be completed by mid-2026. Reuters reports: Read more here. Economic data: New York Fed one-year inflation expectations (May); Wholesale trade sales month-over-month (April) Earnings: Casey's (CASY) Here are some of the biggest stories you may have missed overnight and early this morning: All eyes on AI as Apple takes the stage for WWDC A quieter summer is coming for stocks: Wall Street experts Hopes for US-China thaw as trade talks resume Senate GOP to lay out major revisions to Trump's tax bill Resilient economy to limit summer pullback in stocks: MS, Goldman Meta is set to throw billions at startup that leads in AI data China exports to US fall by most since 2020 despite tariff truce Here are some top stocks trending on Yahoo Finance in premarket trading: Robinhood (HOOD) stock fell 5% before the bell on Monday after the S&P Dow Jones Indices made no changes to the S&P 500 in its quarterly rebalancing. Tesla (TSLA) stock also dropped on Monday in premarket trading after CEO Elon Musk criticized President Trump's tax bill. Strategy (MSTR) stock rose on Monday by 2%. A SEC filing revealed the company had purchased 705 bitcoin during the period of May 26 to June 1 at an aggregate purchase price of $75.1M. Wall Street strategists are growing optimistic about US stocks, with forecasters at Morgan Stanley (MS) and Goldman Sachs Group (GS) the latest to suggest resilient economic growth would limit any pullback over the summer. Bloomberg reports: Read more here. Circle's stock (CRCL) surged for a third day in a row on Monday following its blockbuster IPO last week. Shares of the stablecoin issuer gained more than 15% to trade near $122 per share, raising the company's market cap to roughly $24 billion. The move follows gains on Thursday and Friday, when the stock rose as much as 200% shortly after its long-anticipated public market debut. Stocks edged higher on Monday amid hopes that US-China trade talks will ease tariff tensions and eventually lead to a permanent deal between the two leading economies. The S&P 500 (GSPC) rose to just above the flat line, after the broad benchmark closed on Friday at its highest level since February. The Dow Jones Industrial Average (^DJI) gained 0.1%, while the tech-heavy Nasdaq Composite (^IXIC) edged 0.2% higher. High-level trade talks between Beijing and Washington began in London on Monday. This follows a phone call between President Trump and Chinese leader Xi Jinping last week. Apple's annual Worldwide Developers Conference (WWDC) kicks off in Cupertino, Calif., today. While investors may get another taste of artificial intelligence features, including AI-powered Siri, Apple isn't expected to deliver any big announcements. The company will likely showcase new features and designs for iOS, iPadOS, macOS, and watchOS. There's always a chance it will debut a new piece of hardware too. Apple (AAPL) stock rose 0.5% in premarket trading ahead of the event. Read our tech editor's preview of everything to expect from Apple WWDC 2025. Robinhood (HOOD) stock slipped 4% after it didn't make it into the benchmark S&P 500 index as some speculated it might. S&P Dow Jones Indices did not make any changes to S&P 500 membership as part of its quarterly rebalancing. Reuters reports: Read more here. Shares of Warner Bros. Discovery (WBD) rose more than 6% in premarket trading on Monday after the media company said it would split into two companies. Warner Bros. will separate its studios and streaming business, which includes HBO Max, and its cable television networks, including CNN. The split is expected to be completed by mid-2026. Reuters reports: Read more here. Economic data: New York Fed one-year inflation expectations (May); Wholesale trade sales month-over-month (April) Earnings: Casey's (CASY) Here are some of the biggest stories you may have missed overnight and early this morning: All eyes on AI as Apple takes the stage for WWDC A quieter summer is coming for stocks: Wall Street experts Hopes for US-China thaw as trade talks resume Senate GOP to lay out major revisions to Trump's tax bill Resilient economy to limit summer pullback in stocks: MS, Goldman Meta is set to throw billions at startup that leads in AI data China exports to US fall by most since 2020 despite tariff truce Here are some top stocks trending on Yahoo Finance in premarket trading: Robinhood (HOOD) stock fell 5% before the bell on Monday after the S&P Dow Jones Indices made no changes to the S&P 500 in its quarterly rebalancing. Tesla (TSLA) stock also dropped on Monday in premarket trading after CEO Elon Musk criticized President Trump's tax bill. Strategy (MSTR) stock rose on Monday by 2%. A SEC filing revealed the company had purchased 705 bitcoin during the period of May 26 to June 1 at an aggregate purchase price of $75.1M. Wall Street strategists are growing optimistic about US stocks, with forecasters at Morgan Stanley (MS) and Goldman Sachs Group (GS) the latest to suggest resilient economic growth would limit any pullback over the summer. Bloomberg reports: Read more here.
Yahoo
39 minutes ago
- Yahoo
Pharmaceutical Packaging Market Outlook to 2028 - Rising Demand for Biologics, Aging Population and Increased Healthcare Access, Innovations in Drug Delivery Systems
The global pharmaceutical packaging market, valued at USD 131 billion, is experiencing robust growth due to the increasing demand for biologics and expanding pharmaceutical industry. Stemming from factors like a rising geriatric population and stringent safety regulations, innovations in injectables and sustainable packaging are pivotal. Dominant regions like the U.S., Germany, and Japan drive market leadership through advanced technologies. Emphasizing sustainability, regulatory compliance remains a challenge, yet the future outlook is positive, propelled by increased demand for eco-friendly and patient-centric solutions. Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Packaging Market Outlook to 2028" report has been added to Pharmaceutical Packaging Market OverviewThe global pharmaceutical packaging market is valued at USD 131 billion, based on a five-year historical analysis. This market growth is largely driven by the increasing demand for biologics and the expansion of the global pharmaceutical industry. The rising geriatric population and the growing prevalence of chronic diseases have spurred the need for innovative packaging solutions, particularly for injectables and complex drug delivery systems. Additionally, stringent regulations regarding drug safety and the adoption of sustainable packaging materials are influencing the dynamics of the market, with an increased focus on product protection and extended shelf pharmaceutical packaging market is dominated by countries such as the United States, Germany, and Japan. The United States leads due to its robust pharmaceutical industry, high healthcare expenditure, and extensive R&D in drug development. Germany's dominance stems from its highly developed pharmaceutical manufacturing sector, while Japan benefits from strong government support for healthcare innovation and a high aging population. These nations are also pioneers in adopting advanced packaging technologies like anti-counterfeiting solutions and eco-friendly packaging materials, further consolidating their leadership in the global worldwide are imposing stricter packaging standards and labeling requirements to ensure drug safety. In the U.S., the FDA updated its packaging and labeling guidelines in 2023, mandating the inclusion of tamper-evident features on all prescription drugs. These regulations are driving pharmaceutical companies to invest in more advanced packaging solutions that meet the new safety standards, such as child-resistant closures and anti-tampering America leads the market due to the presence of major pharmaceutical companies, advanced healthcare infrastructure, and strong regulatory oversight. Additionally, the growing demand for biologics and injectable drugs has propelled the need for innovative packaging solutions in this region. Europe follows closely, driven by a focus on sustainability and eco-friendly packaging materials, with countries like Germany and the UK contributing significantly. Global Pharmaceutical Packaging Market SegmentationBy Product Type: The global pharmaceutical packaging market is segmented by product type into plastic bottles, blister packs, pre-filled syringes, vials and ampoules, and pouches. Recently, pre-filled syringes have gained a dominant market share under this segment due to the increased demand for biologics and vaccines that require injectable solutions. The convenience and precision dosing offered by pre-filled syringes make them a preferred option in healthcare settings, especially in hospitals and outpatient clinics. Additionally, the rising focus on patient safety and the reduction of contamination risks has further strengthened the growth of this Material Type: The market is segmented by material type into plastics & polymers, glass, aluminum foil, and paper & paperboard. Plastics & polymers dominate the market primarily due to their flexibility, durability, and cost-effectiveness. This material type is widely used for packaging solutions such as blister packs, plastic bottles, and pouches. Moreover, the development of biocompatible and biodegradable plastics for pharmaceutical packaging has further driven demand in this segment. The recyclability of polymer-based packaging also aligns with growing environmental concerns, pushing this material type to the forefront of pharmaceutical Pharmaceutical Packaging Market Growth DriversRising Demand for Biologics: Biologics, which are complex medicines derived from living organisms, have seen increased demand globally. According to data from the World Bank, the global biologics market value in 2023 was estimated at over $300 billion. This growing demand for biologics significantly impacts the pharmaceutical packaging market, as biologics require specialized packaging to maintain stability and efficacy. The demand for injectable biologics, such as insulin, has grown due to the rising prevalence of chronic diseases like diabetes. This has driven the need for sterile packaging solutions and has boosted packaging innovations specifically for Population and Increased Healthcare Access: As of 2023, approximately 10% of the global population is aged 65 and older, as reported by the United Nations. This growing aging demographic is increasing the consumption of pharmaceuticals, particularly in developed countries where healthcare access is widespread. In 2023, healthcare expenditure globally reached $8.5 trillion, according to IMF reports. This increase in healthcare spending, combined with higher pharmaceutical consumption, is leading to higher demand for packaging solutions that cater to senior-friendly designs, such as easy-to-open and tamper-proof in Drug Delivery Systems: Innovations in drug delivery systems, particularly prefilled syringes and self-administered packaging solutions, are driving demand in the pharmaceutical packaging market. By 2023, prefilled syringes accounted for a significant portion of drug delivery packaging, with over 5 billion units produced globally, according to the World Health Organization. This growth stems from the increasing need for more convenient drug delivery methods for patients, particularly in the biologics segment. Packaging companies are developing advanced solutions, such as dual-chamber syringes, to meet the growing demands of this Pharmaceutical Packaging Market ChallengesHigh Regulatory Compliance Costs: Pharmaceutical packaging must comply with stringent regulations globally, which significantly increases costs. As per the U.S. FDA, compliance with packaging and labeling regulations costs the industry over $10 billion annually as of 2023. These regulations ensure the safety, efficacy, and traceability of medicines but also pose challenges for manufacturers in adapting to varying international guidelines. Particularly, biologics and personalized medicine require more complex packaging solutions, which further drive compliance Impact of Packaging Waste: The pharmaceutical industry is responsible for generating millions of tons of packaging waste annually, contributing to environmental concerns. According to the United Nations Environment Programme (UNEP), global plastic packaging waste from the healthcare sector exceeded 5 million tons in 2023. Governments worldwide are tightening regulations around waste management, mandating the use of eco-friendly materials. This poses a significant challenge for pharmaceutical companies, which must balance regulatory compliance with sustainability Pharmaceutical Packaging Market Future OutlookOver the next five years, the global pharmaceutical packaging market is expected to experience substantial growth. This growth will be driven by advancements in drug formulations, a rising focus on patient safety, and the increased adoption of sustainable packaging solutions. Additionally, the rapid expansion of the biologics and biosimilar markets, along with growing demand for sterile and safe packaging options, will contribute to market growth. Further innovation in smart packaging solutions, such as RFID and anti-counterfeiting technologies, will also be a major factor in shaping the future of the Adoption of Sustainable Packaging Solutions: The global shift toward sustainability is pushing pharmaceutical companies to adopt eco-friendly packaging solutions. In 2023, the global market for sustainable packaging solutions in pharmaceuticals was estimated to grow by 12% annually. Biodegradable and recyclable packaging materials are gaining popularity, especially in Europe and North America, where regulations are stringent. The EU, for instance, has introduced mandates that aim for a 50% reduction in single-use plastic packaging in healthcare by 2025, opening up opportunities for manufacturers focusing on Collaborations with Healthcare Providers: Collaborations between pharmaceutical companies and healthcare providers are driving innovation in packaging design to meet the specific needs of various patient populations. In 2023, pharmaceutical companies globally invested over $1 billion in partnerships aimed at developing patient-centric packaging solutions. This collaboration enhances the functionality of packaging, such as easier administration of drugs and improved storage solutions, offering significant opportunities for growth in the pharmaceutical packaging market. Global Pharmaceutical Packaging Market Analysis Growth Drivers Rising Demand for Biologics Aging Population and Increased Healthcare Access Innovations in Drug Delivery Systems Government Initiatives on Healthcare Expenditure Market Challenges High Regulatory Compliance Costs Environmental Impact of Packaging Waste Volatility in Raw Material Prices Complexity in Packaging Design for Sensitive Drugs Opportunities Expansion in Emerging Markets (Latin America, Asia-Pacific) Increasing Adoption of Sustainable Packaging Solutions Technological Advancements in Smart Packaging Strategic Collaborations with Healthcare Providers Trends Surge in Demand for Personalized Medicine Packaging Integration of Track-and-Trace Technologies (IoT, RFID) Growth in Flexible and Unit Dose Packaging Increase in Use of Biodegradable and Recyclable Materials Government Regulations Packaging Standards and Drug Labeling Requirements Anti-Counterfeiting Regulations Waste Management Directives and Packaging Sustainability Pharmaceutical Serialization Laws SWOT Analysis Stakeholder Ecosystem Porters Five Forces Analysis Competitive Ecosystem Analysis Global Pharmaceutical Packaging Market Competitive Analysis Amcor Limited Gerresheimer AG Schott AG Berry Global, Inc. West Pharmaceutical Services, Inc. AptarGroup, Inc. Becton, Dickinson & Co. WestRock Company Nipro Corporation Owens-Illinois, Inc. Mondi Group CCL Industries Inc. Ardagh Group Catalent, Inc. Uhlmann Group For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
39 minutes ago
- Yahoo
CEOs walk a 'delicate dance' in US–China negotiations
CEOs are showing up in London as US and Chinese officials meet for trade talks, hoping to shape outcomes behind the scenes. Brown University political science professor Wendy Schiller joins Morning Brief to explain how corporate influence could affect tariff negotiations and political pressure at home. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
